October 5, 2023
Long COVID & Post-Viral Syndromes ECHO
Dysautonomia, Who's in the Driver's Seat?
Bateman Horne Center and the University of Utah Health ECHO teams join forces once again to provide a case-based learning series illuminating strategies for assessment and management of Long COVID (PASC), ME/CFS, and related comorbid conditions.
Patient cases are shared in this session for educational purposes. In some cases, the information does not relate to an individual, and instead represents a compilation of disease presentation. In cases involving individual patient information, the patients have authorized the discussion of their case in this setting.
In the first session, Brayden Yellman, MD, and Jennifer Bell, FNP-C discuss three different cases where dysautonomia is driving the complex multisystem presentation. Each provider offers insight into their clinical approach and treatment strategies.
Case 1: Hypertensive Urgency & Psychogenic Non-Epileptic Seizure
Take aways: Psychogenic non-epileptic seizures may be related to inadequate cerebral perfusion in the context of uncontrolled dysautonomia. Uncontrolled dysautonomia can lead to profound sympathetic hypertensive responses that actually improve with the same treatments used for orthostatic hypotension
Case 2: Anxiety
Take aways: Drill down to the cause of the feelings of anxiety; uncontrolled dysautonomia can drive POTS and sympathetic overdrive.
Case 3: Uncontrolled Mast Cell Activation Syndrome (MCAS)
Take aways: Physiological stress as the result of dysautonomia can drive other pathologies, like mast cell activation syndrome (MCAS).
Note to community members: We advise viewers to always speak with their medical care team prior to making any adjustments or changes to their current regimen.
Bateman Horne Center’s involvement in this program is made possible with the additional support of the Open Medicine Foundation.
TIME STAMPS
00:00 Introduction
01:39 Case 1 Hypertensive Urgency and Psychogenic Nonepileptic Seizure
21:24 Case 2 Anxiety
38:16 Uncontrolled Mast Cell Activation Syndrome (MCAS)
45:33 Question and Answer